key: cord-0713283-wq3ulivi
authors: Brawner, Clinton A.; Ehrman, Jonathan K.; Bole, Shane; Kerrigan, Dennis J.; Parikh, Sachin S.; Lewis, Barry K.; Gindi, Ryan M.; Keteyian, Courtland; Abdul-Nour, Khaled; Keteyian, Steven J.
title: Maximal Exercise Capacity is Inversely Related to Hospitalization Secondary to Coronavirus Disease 2019
date: 2020-10-10
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2020.10.003
sha: 2c09263391fccef3b9b3702360601f19804be12e
doc_id: 713283
cord_uid: wq3ulivi

Objective To investigate the relationship between maximal exercise capacity measured before severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and hospitalization due to coronavirus disease 2019 (COVID-19). Patients and Methods We identified patients (≥18 years) who completed a clinically indicated exercise stress test between 01 January 2016 and 29 February 2020 and had a test for SARS-CoV-2 (i.e., real-time reverse transcriptase polymerase chain reaction test) between 29 February 2020 and 31 May 2020. Maximal exercise capacity was quantified in metabolic equivalents of task (METs). Logistic regression was used to evaluate the likelihood that hospitalization secondary to COVID-19 is related to peak METs, with adjustment for 13 covariates previously identified as associated with higher risk for severe illness from COVID-19. Results We identified 246 patients (age= 59±12 years; 42% male; 75% black race) who had an exercise test and tested positive for SARS-CoV-2. Among these, 89 (36%) were hospitalized. Peak METs were significantly lower (P <.001) among patients who were hospitalized (6.7±2.8) compared to those not hospitalized (8.0±2.4). Peak METs were inversely associated with the likelihood of hospitalization in unadjusted (OR= 0.83, 95% CI= 0.74, 0.92) and adjusted models (OR= 0.87, 95% CI= 0.76, 0.99). Conclusion Maximal exercise capacity is independently and inversely associated with the likelihood of hospitalization due to COVID-19. These data further support the important relationship between cardiorespiratory fitness and health outcomes. Future studies are needed to determine if improving maximal exercise capacity is associated with lower risk of complications due to viral infections, such as COVID-19.

Respiratory viral infections, like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cause a systematic inflammatory response which places a substantial burden on the cardiopulmonary system. Higher cardiorespiratory fitness (e.g., exercise capacity) is reflective of a greater cardiopulmonary reserve and the body's ability to respond to an insult, as well as inversely related to risk for adverse outcomes among individuals diagnosed with a chronic disease 1-6 . Fitness is moderated by age, genomics, and presence of chronic disease, and is heavily influenced by physical activity, especially structured exercise training 6, 7 . In addition to improving fitness, cardiorespiratory (e.g., aerobic type) exercise training improves immune function, reduces chronic low-grade inflammation, and lowers the risk of respiratory infections 8, 9 .

Numerous studies have identified factors associated with worsening clinical outcomes among patients with coronavirus disease 2019 (COVID-19), including pre-existing comorbidities (e.g., pulmonary disease, heart disease) 10 , lifestyle factors (e.g., smoking, obesity) 10-12 , and demographic characteristics (e.g., male, older age) 10, 11 . Yet to be described among patients who test positive for the disease, is the association between maximal exercise capacity and risk of COVID-19 related complications.

The purpose of this retrospective study was to investigate the relationship between maximal exercise capacity measured during a clinically indicated exercise stress test performed before SARS-CoV-2 infection and hospitalization due to COVID-19. We hypothesized that maximal exercise capacity would be independently and inversely related to hospitalization due to J o u r n a l P r e -p r o o f

For this retrospective observational study, we included adults (≥18 years) who completed a clinically indicated exercise stress test on a treadmill between 01 January 2016 and 29 February 2020 within the Henry Ford Medical Group and had a test for SARS-CoV-2 between 29 February and 30 May 2020. Hospitalizations were identified through a minimum of 30 days after the SARS-CoV-2 test and discharge disposition was queried through 31 July 2020. Patients were identified via a query of the clinical reporting system used to create exercise stress test reports (details below; see Figure 1 ). Patients were excluded if the exercise protocol or exercise test duration were incomplete. When more than one test was available for a given patient, only the most recent test was included. SARS-CoV-2 was detected using real-time reverse transcriptase polymerase chain reaction tests. This study was approved by the Henry Ford Health System institutional review board and informed consent was waived.

Exercise tests types were electrocardiography only, electrocardiography + echocardiography (e.g., stress echo), and cardiopulmonary exercise tests. Tests were supervised by clinical exercise physiologists, nurses, and/or cardiovascular technicians. Prior to the test, cardiovascular risk factors and relevant medical history were reviewed by staff using the medical record and patient interview. Exercise tests were conducted consistent with American Heart Association guidelines 13 . The supervising clinician selected the exercise protocol, with the Bruce and modified Bruce protocols most often chosen. Patients were verbally encouraged to provide a sign or symptom-limited maximal effort. A preliminary report that included demographics, cardiovascular risk factors, relevant medical history, and rest and exercise data was created by the supervising clinician using a clinical reporting system (Syngo Dynamics, Siemens Medical Solutions, Pennsylvania, USA). This report was subsequently reviewed by a reading cardiologist and uploaded to the medical record (Epic, Epic Systems Corporation, Verona, Wisconsin, USA).

Demographic, clinical, rest, and exercise data collected at the time of the exercise test were extracted from the clinical reporting system used to create the exercise test report for the medical record. These data were complemented with data from the health system's electronic data warehouse which contains clinical (outpatient and inpatient), laboratory, financial, and medication data from the electronic medical record. Using ICD-10 codes (see Supplemental   Table 1 ), clinical data were extracted from the data warehouse for patients who completed an exercise test and had a test for SARS-CoV-2. These data included hypertension, diabetes mellitus, heart failure, myocardial infarction, coronary artery bypass graft surgery, percutaneous coronary intervention, cerebrovascular accident, chronic obstructive pulmonary disease, asthma, chronic kidney disease, and liver disease. History of any cancer was identified from the Henry Ford Cancer Institute's tumor registry. Body mass index was calculated based on the most recent height and weight available from the electronic medical record prior to SARS-CoV-2 test. If either were unavailable, then data from the exercise test was used. Tobacco smoking was based on patient interview at the time of the exercise test. 

Between group comparisons were made using 2-sided t-test and Chi-square for continuous and nominal data, respectively. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (CI) for SARS-CoV-2 infection based on peak METs (continuous variable). Logistic regression was also used to evaluate the likelihood that hospitalization secondary to COVID-19 is related to peak METs (in both quartiles and continuous). For our primary analysis, logistic regression was used with peak METs as a continuous variable with adjustment for conditions based on those that the Centers for Disease Control and Prevention have identified as representing definite or possible increased risk for severe illness from COVID-19 15 . The included covariates were age at the time of SARS-CoV-2 test ≥65 years, sex, history of asthma, cancer, cerebrovascular accident, chronic kidney disease, chronic obstructive pulmonary disease, coronary heart disease (i.e., coronary artery disease, myocardial infarction, or coronary revascularization), diabetes mellitus (type 1 or 2), heart failure, hypertension, obesity (body mass index ≥30 kg·m -2 ), and tobacco smoking. Liver disease was not present in our cohort. Alpha level was <.05. Continuous data are presented as mean ± standard deviation unless noted otherwise. Statistical analyses were performed using IBM SPSS Statistics v24.

We identified 1,181 adult patients who had an exercise stress test, a test for SARS-CoV-2, and complete data to be included in the analysis (see Figure 1 ). Exercise test indications were chest J o u r n a l P r e -p r o o f pain (n= 665, 56%); shortness of breath or fatigue (n= 191, 16%); abnormal electrocardiogram or abnormal functional study (n= 86, 7%); heart failure evaluation (n= 66, 6%); heart rate or rhythm evaluation (n= 59, 5%); pre-surgical evaluation, screening for cardiovascular disorder, or assess exercise capacity (n= 44, 4%); known coronary heart disease (n= 42; 4%); and other (n= 28, 2% Characteristics of the 246 patients who tested positive for SARS-CoV-2 are shown in Table 1 . Among these patients, 89 (36%) were hospitalized. Compared to those who were not hospitalized for COVID-19, patients who were hospitalized were significantly older and more likely to have hypertension, diabetes mellitus, coronary heart disease, chronic kidney disease, and heart failure. Hospitalized patients were also more likely to be prescribed an antilipemic medication, calcium channel blocker, beta-blocker, diuretic, insulin, and an antiplatelet/coagulant. Among the hospitalized patients, median length of stay was 13 days (range: 1-57 days), 28 were admitted to the intensive care unit (median stay= 6 days, range: 1-27 days), 8 were put on a ventilator, and 13 died. There was no significant difference in mean METs (P= Results from the logistic regression analysis with the covariates sorted by their Wald χ 2 are shown in Table 2 . Peak METs (continuous variable) were inversely associated with the likelihood of hospitalization in unadjusted and adjusted models. Each unit higher of peak METs was independently associated with a 13% (adjusted OR= 0.87; 95% CI= 0.76, 0.99) lower odds of hospitalization. There was no significant interaction for peak METs by sex (P=.99), age < vs.

≥65 years (P=.95), or obese vs. not obese (P=.08). As shown in Figure 3 , there is a steady decline in the predicted probability of hospitalization with increasing peak METs with a nadir near 13 METs.

In a diverse cohort of patients who tested positive for SARS-CoV-2, we showed an independent and inverse association between maximal exercise capacity and likelihood of hospitalization for COVID-19, a finding consistent with our hypothesis. One MET higher of exercise capacity was associated with 13% lower odds for hospitalization. This might be the first report of maximal exercise capacity as a predictor of hospitalization due to viral infection.

Cardiorespiratory fitness or exercise capacity directly reflects the integrated function of multiple organ systems. As such, it is an important measure of overall health and the body's ability to respond to internal and external stressors 6 , such as COVID-19. Akin to this is the practice of measuring exercise capacity prior to surgery in order to categorize a patient's ability to tolerate the perioperative "cardiopulmonary burden" associated with general anesthesia and the sustained increase in oxygen demand after surgery 2, 5 . COVID-19 represents another burden or stressor on the cardiopulmonary system, providing a potential physiologic explanation for the observed inverse association between maximal exercise capacity and risk for hospitalization.

Finally, this association is consistent with prior findings in patients referred for an exercise stress test 16, 17 and those with a chronic disease, including coronary artery disease 3 , chronic kidney disease 1 , and heart failure 4 .

There is additional physiologic rationale for our findings, and it involves first appreciating that an individual's exercise capacity is greatly influenced by their physical activity and exercise training habits. Although genetics, age, and the presence of chronic disease also influence exercise capacity, the volume of exercise that one routinely engages in is associated with risk of infection, modeled as a "J-shaped" curve 8, 9 . Specifically, moderate intensity aerobictype exercise enhances immune function above that observed with sedentary behavior, and repeated high intensity exercise performed for prolonged duration may impair immune function and increase the risk for infection 8, 9 . In summary, regular moderate to vigorous intensity aerobic exercise is an important contributor to exercise capacity and favorably influences biologic pathways that are involved with the body's response to an infection 9 .

The implications of our findings are important for several reasons. First, like smoking and obesity, exercise capacity is a modifiable factor that could be a target for preventive J o u r n a l P r e -p r o o f strategies (e.g., regular exercise) aimed at attenuating disease-specific complications. Second, exercise capacity was one of the strongest predictors of hospitalization among patients positive for SARS-CoV-2 (Wald χ 2 = 4.18, Table 2 ) and could be used for risk stratification. Third, the association we identified may be an important consideration for future trials that investigate factors associated with disease-specific complications. Such trials might consider exercise capacity as a covariate or an unmeasured confounder.

Our study is not without limitations. First, we acknowledge the possibility of residual confounding due to unmeasured behavioral or clinical characteristics. Important among these, we do not have data on physical activity or tobacco smoking habits between the time of the exercise test and SARS-CoV-2 infection. Second, exercise capacity may have changed between the time of the exercise tests and SARS-CoV-2 infection (median= 2.1 years). However, in a prior study we reported 18 that over a median of 3.8 years between two exercise tests, there was minimal change in exercise capacity among men (median= 0.3 METs; 25 th , 75 th percentile= -2.1, 0.6 METs). Similar values were observed in women. Third, as a retrospective study we risk misclassification of chronic disease status, especially among patients who were not hospitalized because these patients might have obtained additional healthcare at another health system.

Strengths of this study include the racially diverse cohort and the inclusion of several covariates that are currently suspected of increased risk due to SARS-CoV-2.

Although risk of viral infections associated with change in fitness or changes in physical activity habits are beyond the scope of the present analysis, these data reinforce several important public health messages. First, both volume of physical activity and exercise capacity are inversely related to risk of infection, incident chronic disease, and health outcomes among individuals with and without chronic disease. 6, 19 Second, change in both physical activity and J o u r n a l P r e -p r o o f exercise capacity are inversely associated with health outcomes. 6, 19 Third, increasing physical activity, especially through structured exercise training, is the primary means for most people to increase exercise capacity. 19 Collectively, these support the importance of identifying alternate avenues that allow individuals to maintain and preferable increase physical activity levels when normal activities might be restricted by local health authorities in response to a public health crisis, as has occurred in many regions during the COVID-19 pandemic.

In conclusion, maximal exercise capacity determined from an exercise stress test prior to SARS-CoV-2 infection is independently and inversely associated with the likelihood of hospitalization due to COVID-19. These data further support the important relationship between cardiorespiratory fitness and health outcomes. Patients should be encouraged to regularly engage in aerobic exercise to maintain or improve their exercise capacity. Future studies are needed to determine if improving exercise capacity is associated with lower risk of complications due to viral infections, such as COVID-19.

Brawner 

Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance

ACC/AHA guideline on Excluded (in order of processing; n= 3,008): 1. No medical record number (n= 28) 2. No protocol or exercise duration

Non-standard exercise protocol

005): no SARS-CoV-2 test SARS-CoV-2 test and complete data (n= 1,181) Excluded (n= 2): missing body mass index